Disclosure Panels Details Page
Cervical/Uterine Cancers Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Nadeem Abu-Rustum MD | GRAIL | NCCN | NCCN | None | 04/19/2023 |
| Shaili Aggarwal PhD | None | None | None | GlaxoSmithKline | 02/21/2023 |
| Rebecca Arend MD | Champions Oncology, Inc. Exelixis Inc. GlaxoSmithKline ImmunoGen, Inc. Merck & Co., Inc. VBL Therapeutics |
GSK Kiyatec Merck & Co., Inc. Seagen Inc. SUTRO Biopharma, Inc. VBL Therapeutics |
Natera | None | 03/21/2023 |
| Emma Barber MD | Eli Lilly and Company | Merck & Co., Inc. | None | None | 05/14/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Kristin Bradley MD | None | None | None | American Brachytherapy Society|UpToDate, contributing author | 01/21/2023 |
| Rebecca Brooks MD | None | AstraZeneca Pharmaceuticals LP GlaxoSmithKline O'Neill McFadden & Willett LLP |
AstraZeneca Pharmaceuticals LP GlaxoSmithKline |
None | 12/18/2022 |
| Susana Campos MS,MD,MPH | None | AstraZeneca Pharmaceuticals LP Eisai Inc. GlaxoSmithKline Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | 12/27/2022 |
| Junzo Chino MD | KM Pharmaceutical Consulting LLC | None | Stryker | None | 05/19/2023 |
| Hye Sook Chon MD | None | Clinical Education Alliance Eisai Inc. |
None | None | 03/10/2023 |
| Marta Ann Crispens MD | AstraZeneca Pharmaceuticals LP | None | None | None | 05/18/2023 |
| Shari Damast MD | None | None | None | None | 02/12/2023 |
| Christine Fisher MPH,MD | None | None | None | None | 01/12/2023 |
| Peter Frederick MD | None | None | None | None | 03/08/2023 |
| David Gaffney MD,PhD | Elekta | Merck & Co., Inc. | None | None | 04/12/2023 |
| Stephanie Gaillard PhD,MD | AstraZeneca Pharmaceuticals LP Clovis Oncology Compugen Genentech, Inc. GlaxoSmithKline Tempest |
ImmunoGen, Inc. Lumanity Verastem |
None | None | 02/09/2023 |
| Robert Giuntoli II MD | AstraZeneca Pharmaceuticals LP | Buckingham, Doolittle & Burroughs, LLC McCumber, Daniels, Buntz, Hartig, Puig & Ross P.A. Moscarino & Treu LLP Rawle & Henderson, LLP Stahl & DeLaurentis, P.C. |
None | None | 02/23/2023 |
| Scott Glaser MD | Aiden Industries | None | None | None | 05/23/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Jordan Holmes MD,MPH | None | None | None | None | 01/16/2023 |
| Brooke Howitt MD | None | Cartography Biosciences Santa Ana Bio |
None | None | 03/23/2023 |
| Kari Kendra MD,PhD | Amgen Inc. checkmate pharmaceuticals Istari oncology medspace Merck & Co., Inc. National Institute on Aging Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | None | 12/24/2022 |
| Jayanthi Lea MD | None | None | None | None | 04/19/2023 |
| Gina Mantia-Smaldone MD | None | None | None | None | 01/17/2023 |
| Andrea Mariani MD | None | None | None | None | 03/06/2023 |
| Nicole McMillian MS | None | None | None | None | 05/23/2023 |
| David Mutch MD | None | None | None | None | 02/07/2023 |
| Christa Nagel MD | None | None | None | None | 05/24/2023 |
| Larissa Nekhlyudov MD,MPH | None | None | None | None | 12/29/2022 |
| Sharon Park PharmD,BCOP | None | None | None | None | 05/09/2023 |
| Mirna Podoll MD | None | None | None | None | 06/09/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Kerry Rodabaugh MD | Immunovaccine Technologies | None | None | None | 01/21/2023 |
| Ritu Salani MBA,MD | Genentech, Inc. Merck & Co., Inc. |
GlaxoSmithKline ImmunoGen, Inc. Merck & Co., Inc. Mersana Regeneron Pharmactcls Seattle Genetics, Inc. |
None | Elsevier|UpToDate | 04/30/2023 |
| John Schorge MD | None | None | None | None | 02/06/2023 |
| Scott Schuetze PhD,MD | Adaptimmune Advenchen Ayala Pharmaceuticals BioAtla Boehringer Ingelheim GmbH Epizyme GlaxoSmithKline Karyopharm Therapeutics RAIN Therapeutics TRACON Pharmaceuticals, Inc. |
Adaptimmune Boehringer Ingelheim GmbH |
UpToDate | UpToDate | 08/17/2022 |
| Jean Siedel MS,DO | None | None | None | None | 04/20/2023 |
| Rachel Sisodia MD | None | None | None | None | 06/28/2022 |
| Pamela Soliman MD,MPH | Incyte Corporation Novartis Pharmaceuticals Corporation |
Aadi Bioscience, Inc. Amgen Inc. Clovis Oncology Eisai Inc. GlaxoSmithKline Karyopharm Therapeutics Medscape |
None | None | 04/20/2023 |
| Stefanie Ueda MD | None | None | None | None | 03/08/2023 |
| Renata Urban MD | None | None | Clinical Care Options, Inc. | Royalties received as author, UpToDate, Inc. | 02/02/2023 |
| Erin Vidic | None | None | None | None | 02/13/2023 |
| Amanda Visnick OCN,RN,BSN | None | None | None | None | 02/24/2023 |
| Stephanie Wethington MD,MSc | AstraZeneca Pharmaceuticals LP | AstraZeneca Pharmaceuticals LP GlaxoSmithKline |
None | None | 04/13/2023 |
| Emily Wyse BA | None | None | None | None | 05/01/2023 |
| Catheryn Yashar MD | None | None | None | None | 04/12/2023 |
| Kristine Zanotti MD | None | None | None | None | 06/20/2022 |